
Loading, please wait...

Loading, please wait...

In the evolving landscape of precision medicine, oncology clinical trial curation has become a cornerstone for connecting patients with life-saving research. Digital platforms like LookUpTrials are designed to assist clinicians in navigating complex trial landscapes. However, the manual effort required to keep these platforms updated often poses a sustainability challenge. A recent study published in JMIR Formative Research explores a "human-in-the-loop" model where supervised trainees maintain high-quality trial data. This approach ensures that the platform remains a reliable tool for point-of-care navigation.
The study evaluated a ten-month training program involving undergraduate students. These trainees processed information from ClinicalTrials.gov and various institutional portals. Surprisingly, even individuals without prior clinical trials experience successfully managed the workload. This was possible because the program utilized a structured onboarding process and peer support. Consequently, the team curated 2,503 trial entries across five academic medical centers. Furthermore, their processing rates increased over time, demonstrating the feasibility of the workflow.
Effective oncology clinical trial curation provides several advantages for both clinicians and researchers. Specifically, it transforms raw, unstructured data into actionable insights for site-specific trial matching. Additionally, human-in-the-loop systems mitigate the errors often found in fully automated AI summarization. Because humans oversee the final output, the data integrity remains high. Therefore, this model supports a scalable and durable content pipeline for digital health platforms. It also offers a blueprint for other institutions looking to implement similar data stewardship programs.
Human-in-the-loop curation is a workflow that combines the speed of artificial intelligence with the accuracy of human oversight. In this study, AI assisted with search and summarization, while human trainees verified and refined the trial data.
Yes. The study demonstrated that with structured training, standardized workflows, and quality assurance protocols, individuals without prior clinical experience can effectively curate complex trial information.
By ensuring that trial databases are up-to-date and accurate, the program helps oncologists identify the best possible clinical trials for their patients during consultations, potentially improving access to novel treatments.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Healthcare professionals should exercise their clinical judgment and verify information with primary research sources. Refer to the latest local and national guidelines for clinical practice.
References
Issa M et al. Development and Evaluation of a Human-in-the-Loop Data Curation Training Program to Support a Digital Clinical Trial Platform: Descriptive Feasibility Study. JMIR Form Res. 2026 Mar 25. doi: 10.2196/81257. PMID: 41880602.
Haggstrom DA et al. The My Cancer Genome clinical trial data model and trial curation workflow. J Am Med Inform Assoc. 2020 Jun 1;27(6):893-901. doi: 10.1093/jamia/ocaa033.
Leister S. Advanced Training for CRCs. CITI Program. 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study in JMIR Formative Research evaluates a training program for human-in-the-loop oncology clinical trial data curation, improving digital trial platfor...
5 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today